HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

ABVG protocol

Gemcitabine added to doxorubicin, bleomycin, and vinblastine for treatment of de novo Hodgkin's disease
Networked: 0 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results